Loading...

DFNS T3 DEFENSE INC Capital Structure Changes 8-K Filing

T3 D

DFNS

T3 DEFENSE INC

(DFNS)

2024 8-K

Note Exchange Agreement

Loan Agreement Details

Quarterly Results Announced

Asset Acquisition

Proposed Acquisition

Debt Cancellation

Acquisition Update

Tiltan Software Featured

Legal Dispute Notification

Warrant Pricing Correction

Private Placement Agreement

Management Change

T3 Defense Acquisition

Investor Presentation Upload

Press Release Issued

Growth Strategy Update

Acquisition Announcement

Acquisition Completed

Acquisition Completed

Stock Warrants Issued

Stockholder Meeting Outcome

CFO Appointment

IPO Closure Announcement

IPO Announcement

Press Release Issued

Press Release Issued

Annual Meeting Results

IPO Announcement

Compliance Regained

Equity Line Agreement

Acquisition Announcement

Private Placement Announced

Nasdaq Compliance Notice

Major Acquisition Completed

Joint Venture Agreement

Exclusive Agreement Signed

Divestment of Assets

Equity Investments

Asset Acquisitions

Asset Acquisitions

Asset Acquisitions

Asset Acquisitions

Fiscal Year Change

Acquisition Agreement

Nasdaq Compliance

Filing Amendment

Financial Restatement

Subsidiary Sale

Private Placement Deal

Acquisition Agreement

Equity Agreement

Delisting Notice

Subsidiary Sale

Stock Split Announcement

Stock Split Approved

Agreement Termination

Nasdaq Compliance Issue

Investment Agreement

Management Change

Agreement and Director Appo...

Settlement Agreement

Management Change

Board Expansion and Appoint...

Changes in capital structure

Nasdaq Compliance

Merger and Name Change

Shareholder Meeting

Promissory Notes Issued

Merger Agreement Amendment

Promissory Note Issued

Entry into Material Agreement

Promissory Notes Issued

Merger of Equals

Merger Agreement

Promissory Note Issued

Promissory Note Issued

Material definitive Agreement

Promissory Note Issued

Promissory Note Issued

Annual Meeting of Shareholders

Merger Agreement Amendment

External Links:

Nukkleus Inc. received a notice from Nasdaq stating that their prior deficiency has been cured and their securities will continue to be listed and traded on Nasdaq.

AI Assistant

T3 DEFENSE INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.